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Objective: To test the relative efﬁcacy of pyriproxyfen and methoprene on mortality,
deformity, inhibition and emergence to adult stages of Culex quinquefasciatus and Aedes
albopictus.
Methods: Serial dilutions (0.01–0.05 mg/L) of methoprene, pyriproxyfen 0.5 water
dispersible granules (WDG) and pyriproxyfen 1.0 WDG were used to assess mortality
and inhibition of 3rd instar larvae of Aedes albopictus and Culex quinquefasciatus. Each
concentration and control was replicated four times in completely randomized design.
Data on larval mortality, growth inhibition, deformities and adult's emergence was
recorded weekly. On the basis of best comparative performance, the efﬁcacy of pyr-
iproxyfen 1.0 WDG at 0.1 g/m3 was also tested in the ﬁeld by collecting treated water
samples monthly for 1–6 months after ﬁeld application. Twenty ﬁve 3rd instar larvae of
Aedes and Culex spp. of the same cohorts were used for bioassays and compared with
larvae in control cups containing 1 L of untreated tap water.
Results: Results revealed variations in fatality of different insect growth regulators
(IGRs) to the 3rd instar larvae of Culex and Aedes mosquitoes. Among the IGRs, pyr-
iproxyfen 1.0 WDG was found best that exhibited signiﬁcantly high emergence inhibition
against Culex and Aedes spp. Based on the results, the IGRs were classiﬁed in terms of
the tested parameters in order of pyriproxyfen 1.0 WDG > pyriproxyfen 0.5
WDG > methoprene. In case of ﬁeld studies, pyriproxyfen 1.0 WDG, pool data of the
entire target treated sites showed minimum adult emergence from water sampled of
habitats treated with 0.1 g/m3 of pyriproxyfen 1.0 WDG.
Conclusions: It is thus concluded that IGRs can be utilized as environment friendly
control measures for Culex and Aedes spp. of mosquitoes on small and large scale. This
will reduce the use of conventional insecticides by the public health authorities and help
in reducing selection pressure of insecticides.1. Introduction
Induced hematophagy in mosquito's species of genera
Anopheles, Culex and Aedes make them key vectors ofpathogens in Pakistan and elsewhere [1–3]. Anopheles spp. are
responsible for deadly malaria [4,5] while Culex spp. breed
predominantly in houses [6] and their females while seeking
blood meal make irritable bites [7] with the potential vector
capacity of Japanese encephalitis virus in Pakistan and else
viewer [5,6,8]. Aedes spp. that result in the transmission of
dengue fever and dengue hemorrhagic fever [9–11] due to
Flaviviridae serotypes; Den I to Den IV [12,13] is exotic in
Peshawar. A survey on population dynamics of Aedes
albopictus (Ae. albopictus) in different areas of Peshawar
Division highlighted that this species is newly introduced in
the area. However, its slightly high population in the more
dense vegetation of the rural and semi-urban areas shows itsticle under the CC BY-NC-ND license (http://
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Entomologists are therefore, worried about the adoptability of
Aedes spp. to the urban and rural environment and also their
subsequent establishment in the remote cities. The conducive
natural habitats in the Peshawar area such as vast agricultural
lands, presence of many rivers, several dams and open
network of agricultural channels from these reservoirs
provide plenty of breeding places for all kind of fresh water
mosquitoes [2,15,16] including Aedes spp. Moreover, the semi
urban and urban communities are overcrowded due to
internal displacement caused by devastating ﬂoods during
2010 in the area; poverty, insecurity and establishment of
temporary camps for internally displaced refugees due to
terrorism provide temporary habitats for breeding of Culex
spp. in Peshawar division. These conditions promote the
chances for the spread of vector born diseases [16] and
consequently may lead to possible epidemics/outbreaks in
different parts of Peshawar division with increased morbidity
and mortality. The entomologists and public health
authorities are therefore, of more concern to handle the
situation in time and avoid the severe sudden outbreak unlike
that of Punjab Province in the year 2011–12.
Presently, no vaccine [17] is available for the prevention of
dengue virus infection at the world level. Therefore, control of
vector mosquito is the only way of dengue management [18].
Mainly, the disease control effort has been made to treat the
dengue infected people for minimizing the number of deaths.
However, no or very little effort has been made to stop or
reduce the number of infected cases through vector breeding
control in environmentally safe way. Ever since dengue cases
were reported in 2007 [18] and the severe epidemic in 2011,
2012 in Lahore, the local public health authorities of Khyber
Pakhtunkhwa (Malaria control program) in collaboration with
Non-Governmental Organizations and entomologists have been
battling the vectors species by using insecticides and larvicides as
the only tool for management. Chemical control is quick and
efﬁcient [19], but pose lethal effects on non target organisms and
result in environmental contamination [20]. It also poses threats of
resistance development in mosquitoes to insecticides [21–25] and
therefore, demands for the necessity of developing alternative
strategies. Different plant extracts possess lethal characters for
suppressing the vector mosquitoes. Oils of cinnamon,
eucalyptus and turpentine are fatal to the larvae of Culex
quinquefasciatus (Cx. quinquefasciatus) and act as attractant to
the adults for oviposition and therefore, may be good
candidates for using in the “attract and kill” strategy of
mosquitoes control programs [26]. Similar studies have shown
that some commonly available plant extracts are lethal to Cx.
quinquefasciatus mosquitoes [27].
Insect growth regulators (IGRs) are special new class of
insecticides complex in addition to four major chemical groups
– chlorinated hydrocarbons, organophosphates, carbamates,
and pyrethroids, that inﬂuence insect mortality and growth
inhibition in safe way [28]. Thus the uses of (IGRs) [29–31] in
integrated approaches of mosquitoes [32–34] are the key areas
to be utilized for the vector control. The physical
management of mosquitoes breeding habitats requires huge
economics investment and in many cases not practical for
low income countries. The current studies were therefore,
planned with the aim to monitor and evaluate the efﬁcacy of
different formulations of IGRs against the Culex and Aedes
spp. of Peshawar division in Khyber Pakhtunkhwa, Pakistan.In this way, the use of formal insecticides can be minimized
and replaced with the safe alternatives in the form of IGRs
and ultimately help in resistant management of vector
mosquitoes.
2. Materials and methods
The relative efﬁcacy of various formulations of IGRs against
Ae. albopictus and Cx. quinquefasciatus was investigated in the
laboratory of Entomology Division, Nuclear Institute for Food
and Agriculture (NIFA), Peshawar, Pakistan during the year
2013. IGRs with serial dilutions (0.01–0.05 mg/L) of metho-
prene, pyriproxyfen 0.5 water dispersible granules (WDG) and
pyriproxyfen 1.0 WDG were used to assess mortality and inhi-
bition of 3rd instars larvae of Ae. albopictus and Cx. quinque-
fasciatus in 500 mL disposable cups containing 100 mL of each
concentration and three drops of 1% NIFA larval diet slurry as
food [35]. Control treatments comprised of water and food only.
Each concentration and the control were replicated four times in
completely randomized factorial design.
2.1. Rearing procedures
A laboratory colony was established by collecting the larvae
from the different breeding habitats having mix culture. Larval
and pupal collections were made with 0.5 L standard iron dip-
pers. The larvae collected were brought into laboratory for
rearing using ventilated plastic bottle (2 L) placed in ice chest
during transportation. Field collected mosquitoes were artiﬁ-
cially blood fed through a ﬂexible membrane (Paraﬁlm M). The
culture was established for both Culex and Aedes species
following the standard mosquitoes rearing procedures of Khan
et al. [35]. Identiﬁcation to the species level was made with the
help of available taxonomic keys [36].
2.2. Bioassays
The granular formulation of IGRs was ground to the uni-
formity of ﬁne particles with a mortar and pestle and agitated for
1 h in distill water. The IGRs were dissolved by w/v to make
stock solution of 10 mg/L. This suspension was subjected in
serial dilution and used to derive ﬁnal concentrations of 0.01–
0.05 mg/L in tap water. The evaluations of IGRs were made
following the methods of Sihuincha et al. [30] and Mulla et al.
[37] with slight modiﬁcation according to our requirements.
Bioassays experiments in the laboratory were conducted in
completely randomized design using different concentration
(0.01–0.05 mg/L) of juvenile hormones mimics (methoprene,
pyriproxyfen 1.0 WDG and pyriproxyfen 0.5 WDG)
separately against 3rd instar larvae of Aedes and Culex spp.
Methoprene was purchased from the market in Analar grade.
While two formulations of the pyriproxyfen was supplied by
Evyol Chemicals group, Lahore, Pakistan for the trails. An F1
generation of the larvae was used in the bioassays. Following
the methods of Sihuincha et al. [30] all materials used for
containing eggs, larvae, or adults over the course of the
experiments were disposed off, after each test for minimizing
the potential contamination of experiments with minute doses
of IGRs. Further care was taken by handling larvae, pupae, or
adults using disposable plastic pipettes. The IGRs were trailed
against the batches of 25 (3rd instar) larvae added to 500 mL
disposable pots containing 100 mL of the above mentioned
Table 1
Deformity, mortality, inhibition and emergence of Aedes species as
inﬂuenced by various formulations of IGRs at different
concentrations. %.
IGRs Deformity Mortality Inhibition Emergence
Methoprene 10.83b 21.67b 38.00a 30.21a
Pyriproxyfen 0.5 WDG 11.00b 32.67a 36.83a 19.67c
Pyriproxyfen 1.0 WDG 14.16a 33.91a 29.50b 21.87b
LSD 0.05 2.42 2.03 1.95 1.75
0.00 (control) 0.00d 7.50e 0.00c 91.83a
0.01 mg/L 17.33b 8.67e 43.67a 30.67b
0.02 mg/L 21.33a 16.67d 45.67a 17.33c
0.03 mg/L 17.00b 34.67c 45.33a 3.00d
0.04 mg/L 9.66c 46.67b 43.00a 0.67de
0.05 mg/L 6.67c 62.33a 31.00b 0.00e
LSD 0.05 3.42 2.87 2.76 2.47
Methoprene × 0.01 mg/L 12.00de 11.00hi 31.00i 49.00b
Methoprene × 0.02 mg/L 20.00bc 15.00gh 37.00h 31.00c
Methoprene × 0.03 mg/L 15.00cd 27.00f 49.00de 9.00e
Methoprene × 0.04 mg/L 12.00de 33.00e 53.00cd 2.00f
Methoprene × 0.05 mg/L 6.00f 36.00de 58.00b 0.00f
Pyriproxyfen 0.5
WDG × 0.01 mg/L
16.00cd 8.00i 55.00bc 21.00d
Pyriproxyfen 0.5
WDG × 0.02 mg/L
18.00c 16.00g 63.00a 3.00f
Pyriproxyfen 0.5
WDG × 0.03 mg/L
16.00cd 40.00d 44.00f 0.00f
Pyriproxyfen 0.5
WDG × 0.04 mg/L
9.00ef 52.00c 39.00gh 0.00f
Pyriproxyfen 0.5
WDG × 0.05 mg/L
7.00ef 73.00b 20.00j 0.00f
Pyriproxyfen 1.0
WDG × 0.01 mg/L
24.00ab 7.00i 45.00ef 22.00d
Pyriproxyfen 1.0
WDG × 0.02 mg/L
26.00a 19.00g 37.00h 18.00d
Pyriproxyfen 1.0
WDG × 0.03 mg/L
20.00bc 37.00de 43.00fg 0.00f
Pyriproxyfen 1.0
WDG × 0.04 mg/L
8.00ef 55.00c 37.00h 0.00f
Pyriproxyfen 1.0
WDG × 0.05 mg/L
7.00ef 78.00a 15.00k 0.00f
LSD 0.05 5.93 4.98 4.78 4.29
Means followed by the same letter(s) in columns are not signiﬁcant at
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consisted of tap water and food only. All pots were capped
with gauze to prevent the escape of emerging adults and were
monitored for 15–21 days. Tests cups were examined daily
and molted exoskeletons, dead larvae or pupae, and emerged
adults were removed. Pupa formed during the course of
experiment were separated through a plastic dropper and put
in disposable cups with 2 mL of water. All cups were covered
with gauze to prevent the escape of emerging adults and
observed for emergence to the adult stage. The whole
experiment was run in laboratory maintained at 12:12 h
photoperiod and (28 ± 2) C. The entire bioassay was
repeated two times under similar conditions.
2.3. Efﬁcacy of IGR under ﬁeld conditions
Pyriproxyfen 1.0 WDG was found the best inhibitor for both
the species in laboratory studies and therefore, its efﬁcacy was
further evaluated under ﬁeld conditions. For this purpose, three
natural mosquito breeding sites of sizes 10.10 m3, 11.00 m3 and
12.53 m3 were used for treatment with pyriproxyfen 1.0 WDG
and 8.00 m3 area as control was selected at Kalamandi (Pesha-
war). All these sites had mix culture of Aedes and Culex spp.
The sites were treated according to the recommended ﬁled dose
at the rates of 0.1 g/m3 in 1 000 L of water. The approximate
volume of water in the site was calculated by length (m) × width
(m) × average depth (m) = cubic meter (m3) water volume.
Pyriproxyfen 1.0 WDG was applied in a pouch bag of muslin
cloth in each replication and suspended in the body of the habitat
with a building wire. Five liters samples of water from the
treated sites were collected and taken to the laboratory for testing
the efﬁcacy as described by Sihuincha et al. [30]. Twenty ﬁve 3rd
instar larvae of Aedes and Culex spp. of the same cohorts were
used for bioassays. These cohorts were compared with larvae in
control cups containing 1 L of untreated tap water. NIFA larval
diet solution at (1%) was added to all cups as a food source as
mentioned above. Percent larval mortality, adult emergence
inhibition, deformities and adult emergence were recorded for
1–6 months after the treatment.
2.4. Statistical analysis
Mean percent larval mortality, deformities and reductions of
adult emergence, in each batch of mosquito species caused by the
IGRs formulations were subjected to the analysis of variance
technique and means were further separated through least signif-
icant difference test using the statistical package (Statistix 8.1).
3. Results
The mean values pertaining to percent larval mortality, de-
formities, inhibition and emergence of Aedes and Culex species
are presented in Tables 1 and 2 respectively.
3.1. Ae. albopictus
The inhibition percentage as calculated against different
IGRs, concentrations and their interaction is expressed in
Table 1. Highest inhibition was recorded for methoprene fol-
lowed by pyriproxyfen 0.5 WDG while lowest was recorded for
pyriproxyfen 1.0 WDG (Table 1). The inhibition percentage asobserved against various concentrations was maximum at
0.02 mg/L which was statistically similar to 0.01, 0.03 and
0.04 mg/L while 0.05 mg/L concentration depicted lowest in-
hibition percentage against Aedes spp. Pyriproxyfen 0.5
WDG × 0.02 mg/L exhibited highest interaction for inhibition
percentage with the value of 63% followed by methoprene at
0.05 mg/L concentration.
In the course of studies, it was observed that minimum
emergence percentage (19.67%) was recorded in pyriproxyfen
0.5 WDG followed by pyriproxyfen 1.0 WDG (21.87%)
whereas maximum in methoprene (Table 1). In testing various
concentrations, no emergence was observed at 0.05 mg/L fol-
lowed by 0.04 mg/L (0.67%) as compared to control where
maximum emergence percentage (91.83%) was noticed. Most of
the treatments exhibited minimum interaction for emergence
percentage except methoprene × 0.01 mg/L where the interac-
tion was 49.00% followed by methoprene × 0.02 mg/L.
The mortality percentage as calculated against different IGRs
was signiﬁcantly different. Highest mortality of 33.91% was
recorded for pyriproxyfen 1.0 WDG which was statistically at
par with pyriproxyfen 0.5 WDG. Lowest mortality was recorded
in methoprene (Table 1). Similarly, various concentrations also5% level of probability.
Table 2
Deformity, mortality, inhibition and emergence of Culex species as
inﬂuenced by various formulations of IGRs at different concentrations.
IGRs Deformity Mortality Emergence Inhibition
Methoprene 25.50a 20.67c 26.83a 28.00b
Pyriproxyfen 0.5 WDG 13.67b 31.21b 18.00b 35.16a
Pyriproxyfen 1.0 WDG 11.33b 42.71a 15.00c 28.67b
LSD 0.05 2.65 2.38 2.99 2.98
0.00 (control) 2.00c 9.16e 89.00a 0.00e
0.01 mg/L 24.00a 12.00e 12.00b 45.67a
0.02 mg/L 21.00a 26.33d 8.67bc 43.00ab
0.03 mg/L 22.67a 31.67c 4.67cd 40.67bc
0.04 mg/L 15.33b 45.33b 2.33d 38.00c
0.05 mg/L 16.00b 64.67a 3.00d 16.33de
LSD 0.05 3.75 3.37 4.24 4.22
Methoprene × 0.01 mg/L 23.00ce 10.00l 24.00a
Non
signiﬁcant
interaction
Methoprene × 0.02 mg/L 30.00b 19.00ij 21.00b
Methoprene × 0.03 mg/L 32.00ab 20.00ij 9.00cd
Methoprene × 0.04 mg/L 29.00bc 28.00gh 7.00ce
Methoprene × 0.05 mg/L 37.00a 40.00ef 9.00cd
Pyriproxyfen 0.5
WDG × 0.01 mg/L
22.00df 10.00l 10.00c
Pyriproxyfen 0.5
WDG × 0.02 mg/L
17.00eh 23.00hi 5.00ce
Pyriproxyfen 0.5
WDG × 0.03 mg/L
17.00eh 30.00g 5.00ce
Pyriproxyfen 0.5
WDG × 0.04 mg/L
13.00gh 47.00d 0.00e
Pyriproxyfen 0.5
WDG × 0.05 mg/L
11.00h 67.00b 0.00e
Pyriproxyfen 1.0
WDG × 0.01 mg/L
27.00bd 16.00jk 2.00de
Pyriproxyfen 1.0
WDG × 0.02 mg/L
16.00fh 37.00f 0.00e
Pyriproxyfen 1.0
WDG × 0.03 mg/L
19.00eg 45.00de 0.00e
Pyriproxyfen 1.0
WDG × 0.04 mg/L
4.00i 61.00c 0.00e
Pyriproxyfen 1.0
WDG × 0.05
0.00i 87.00a 0.00e
LSD 0.05 6.50 5.83 7.34
Means followed by the same letter(s) in columns are not signiﬁcant at
5% level of probability.
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mortality of 62.33% was recorded at 0.05 mg/L followed by
0.04, 0.03 while minimum mortality was noted in control where
no IGR was applied (Table 1). The interaction of various IGRs
with different concentrations was also highly signiﬁcant. Pyr-
iproxyfen 1.0 WDG exhibited maximum mortality at 0.05 mg/L
concentration followed by pyriproxyfen 0.05 WDG at 0.05 mg/
L concentration.
According to mean square values (Table 3), highly signiﬁ-
cant (P  0.01) differences were observed among various IGRs,Table 3
Mean squares of various parameters recorded in Aedes and Culex species.
Source Aedes
df Deformity Mortality Emergence In
Replication 3 129.78 48.80 13.90
IGRs 2 84.66** 1 090.50** 741.80** 5
Conc 5 764.27** 5 957.03** 15 004.00** 3 8
IGRs × Conc 10 36.13* 361.03** 236.30** 7
Error 51 17.46 12.33 9.10
CV% – 34.83 11.93 12.64
CV: Coefﬁcient of variation. *: Signiﬁcant level of P value equal or less thconcentrations of IGRs and its interaction regarding deformity of
Aedes species. Highest deformity (14.16%) for Aedes was
recorded when treated with pyriproxyfen 1.0 WDG. Among
various concentrations maximum deformity was recorded in
0.02 mg/L followed by 0.01 mg/L which was statistically at par
with 0.03 mg/L concentration. The interaction of IGRs with
various concentrations was also highly signiﬁcant (Table 3) and
thus highest deformity (26.00%) was observed in pyriproxyfen
1.0 WDG × 0.02 mg/L.
3.2. Cx. quinquefasciatus
Highly signiﬁcant (P  0.01) differences were observed
among various IGRs, concentrations of IGRs and its interaction
(Table 3) regarding deformity of Culex species.
In the course of studies, it was observed that maximum
deformity (25.50%) was recorded in methoprene followed by
pyriproxyfen 0.5 WDG whereas minimum in pyriproxyfen 1.0
WDG (Table 2). In testing various concentrations, maximum
deformity was observed at 0.01 mg/L which was statistically at
par with 0.02 and 0.03 mg/L whereas minimum deformity
(2.00%) was noticed in control where no IGR was applied. Most
of the treatments exhibited minimum interaction for deformity
except methoprene × 0.05 mg/L (37.00%) which was statisti-
cally similar to the interaction of methoprene × 0.03 mg/L.
The mortality percentage as calculated against different IGRs
was also signiﬁcantly different. Highest mortality of 42.71% was
recorded for pyriproxyfen 1.0 WDG followed by pyriproxyfen
0.5 WDG. Whereas, lowest mortality was recorded in metho-
prene (Table 2). Similarly various concentrations also signiﬁ-
cantly affected the mortality of Culex species. Maximum
mortality of 64.67% was recorded at 0.05 mg/L followed by
0.04, 0.03 and so on which were statistically signiﬁcant to each
other, while minimum mortality was noted in control where no
IGR was applied (Table 2). The interaction of various IGRs with
different concentrations was also highly signiﬁcant. Pyriprox-
yfen 1.0 WDG exhibited maximum mortality at 0.05 mg/L
concentration followed by pyriproxyfen 0.05 WDG at 0.05 mg/
L concentration (Table 2).
The inhibition percentage as calculated against different
IGRs, concentrations and their interaction is also expressed in
Table 2. Highest inhibition (35.16%) was recorded for pyr-
iproxyfen 0.5 WDG while lowest was recorded for methoprene
(Table 2). The inhibition percentage as observed against various
concentrations was maximum at 0.01 mg/L which was statisti-
cally similar to 0.02 while lowest inhibition percentage against
Culex species was recorded in control.
In the course of studies, it was observed that minimum
emergence percentage (15.00%) was recorded in pyriproxyfenCulex
hibition Deformity Mortality Emergence Inhibition
20.44 15.04 20.54 21.00 7.33
09.56** 1 384.67** 2 916.85** 908.20** 376.22**
40.89** 781.73** 5 273.12** 13 895.20** 4 024.22**
06.09** 247.60** 291.73** 67.20** 31.96
11.35 211.00 16.90 26.80 26.47
9.69 27.22 13.04 25.94 16.81
an 0.05; **: Highly signiﬁcant level of P value equal or less than 0.01.
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whereas maximum in methoprene (Table 2). In testing various
concentrations, minimum emergence was observed at 0.05 mg/L
followed by 0.04 mg/L as compared to control where maximum
emergence percentage (89.00%) was noticed. Most of the
treatments exhibited minimum interaction for emergence per-
centage except methoprene × 0.01 mg/L where the interaction
was 24.00% followed by methoprene × 0.02 mg/L.
3.3. Efﬁcacy of pyriproxyfen 1.0 WDG treatment in the
ﬁeld
The application of pyriproxyfen, 1.0 WDG in ﬁeld trials
showed signiﬁcant variation when post treated samples were
collected after 1–6 months and tested against the laboratory
colony of Aedes spp. for mortality and inhibition. Percent
mortality (Figure 1) decreased during investigation period and
ranged from 46% to 8% within 6 months period. The highest
percent inhibition was noted after 4 months duration. Minimum
deformity was seen after 1 and 4 months period. No inhibition or
malformation was seen at control action. The data showed high
percent mortality of Aedes larvae after 1 month, inhibition after 2
months and increase in adult emergence after 6 months. Simi-
larly, the efﬁcacy of pyriproxyfen 1.0 WDG treatment in the
ﬁeld showed considerable variations when samples were
collected after 1–6 months and tested against the laboratory
colony of Culex spp. Percent mortality (Figure 2) decreased
during experimental time and ranged from 50% to 10%. Lowest
mortality was seen after 6 months period. Percent inhibition was
also low after 6 months duration. No inhibition or malformation
was seen. However, high emergence was recorded at control
treatment. The highest manifestation of larval mortality was
recorded during ﬁrst month which decreased after 4 months. The
data showed decreasing trend in percent mortality, inhibition and
deformity over time from one to six month.Figure 1. Efﬁcacy of ﬁeld applied pyriproxyfen 1.0 WDG on mortality,
inhibition, deformity and adult emergence of Aedes spp. (3rd instar) after
1–6 months period.
Figure 2. Efﬁcacy of ﬁeld applied pyriproxyfen 1.0 WDG concentrations
on mortality, inhibition, deformity and adult emergence of Culex spp. (3rd
instar) after 1–6 months period.4. Discussion
IGRs is a special new class of insecticides which inﬂuence
insect mortality and growth inhibition in an environment friendly
way. This new control strategy was evaluated for the vector
control and found effective both in the laboratory and ﬁeld
conditions. Previous researchers have also successfully utilized
IGRs as a technique for controlling mosquitoes with pyriprox-
yfen and methoprene. Pyriproxyfen has been studied by previous
investigators, showing high toxicity against Cx. quinquefasciatus
and Ae. albopictus larvae and estimated lethal than methoprene
against Aedes aegypti (Ae. aegypti) larvae. According to Ali et al.
[38], pyriproxyfen was more effective than diﬂubenzuron and
methoprene, and resulted 21.5 times higher toxicity against Ae.
albopictus than of S-methoprene, when using the technical
grade of each IGR. The superior activity of S-31183
(pyriproxyfen) over S-methoprene against Anopheles
quadrimaculatus was reported previously by Estrada and Mulla
[39]. Thus pyriproxyfen, an IGR, is a juvenile hormone mimic
that is highly active against a wide variety of insects of public
health importance, including ﬂeas, tsetse ﬂies, houseﬂies,
cockroaches, imported ﬁre ants, chironomid midges, and
mosquitoes [40]. The emergence inhibition caused by IGRs at
0.001–0.005 mg/L was also acceptable and in accordance to
the study of Trayler et al. [41], who reported that pyriproxyfen
at 0.01 mg/L caused 90% inhibition of chironomid
polypedilum and reduced the emergence of said species. They
further stated that pyriproxyfen at 0.01 mg/L signiﬁcantly
reduced the emergence of Polypedilum nubifer and Kiefferrulus
intmincrus (Skuse) for 24 days. Kawada [42] who reported 50%
emergence inhibition of Ae. albopictus caused by methoprene
at 0.0011 mg/L, diﬂubenzuron at 0.0003 mg/L, and
pyriproxyfen at 0.000024 mg/L. Vythilingam et al. [43]
reported that pyriproxyfen against Ae. aegypti at 0.01 and
0.02 mg/L provided 100% control for 4 months.
Some attractive devices contaminated with pyriproxyfen
have been shown to attract Ae. aegypti towards the station and
results in suppression of Ae. aegypti populations [44]. In other
instances with a fear of vector resurgence due to development
of insecticide resistance, IGRs are potential alternative to
control mosquitoes, in an environment friendly manner [45–47].
Harburguer et al. [48] recorded comparatively low emergence
inhibition (20%–40%) and no ovicidal effect on Ae. aegypti
by releasing pyriproxyfen from a fumigant formulation.
However, they reported that the sublethal doses of
pyriproxyfen can have effects on fertility and fecundity of Ae.
aegypti females, which together with its larvicidal activity
could contribute to an overall decrease in a given population.
Nayar et al. [29] reported that pyriproxyfen at comparable
treatment rates to S-methoprene and caused very high levels
(> 80%–100% in most cases) of initial and residual
emergence inhibitions of the tested Aedes spp. in the
laboratory as well as outdoors.
Our categorization of IGRs in term of efﬁciency is (pyr-
iproxyfen 1.0 WDG > pyriproxyfen 0.5 WDG > methoprene).
This is also in accordance to that of Ali et al. [38] who
categorized the toxicity ranking of chemicals and microbials
tested as IGRs > pyrethroids > organophosphates > microbials.
We observed that 1.0 WDG formulation of pyriproxyfen was
highly effective against the larval stages of Ae. a1bopictus and
Culex spp. in the ﬁeld conditions. In our studies, the mortality,
growth inhibition and adult emergence were kept at low from 1
Gul Zamin Khan et al./Asian Pac J Trop Biomed 2016; 6(6): 485–491490to 4 months period with pyriproxyfen 1.0 WDG in the ﬁeld.
Vythilingam et al. [43] reported that pyriproxyfen against Ae.
aegypti at 0.01 and 0.02 mg/L provided 100% control for 4
months. Sihuincha et al. [30] observed that pyriproxyfen
prevented adult emergence at extremely low concentrations in
the laboratory and ﬁeld conditions. The decrease in the
suppression of the laboratory strain after their exposure to ﬁeld
treated water samples may be due to regular rainfall occurring
experiment that has caused the dilution of water in the treated
habitats. However, these results were still acceptable up to 6
months period.
IGRs, particularly the two formulations of pyriproxyfen
offer an excellent potential for the control of Ae. albopictus
and Culex spp. and require the attention of public health au-
thorities for their use on small scale and area wide control of
mosquitoes in the dengue affected areas. This will not only
increase in the insecticide free package of the environment
friendly program but also help in devising long-term sustain-
able resistant management strategy for vector mosquitoes of
deadly diseases.
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